Blog

Next-Generation HER2-Targeted ADC’s in Breast Cancer – Cancers MDPI

Brittney Shulman Zimmerman and Francisco J. Esteva

Oct 25, 2024, 19:14

Next-Generation HER2-Targeted ADC’s in Breast Cancer – Cancers MDPI

”Check out the Editor’s Choice Article ‘Next-Generation HER2-Targeted Antibody–Drug Conjugates in Breast Cancer‘ by Brittney Shulman Zimmerman and Francisco J. Esteva.

I believe that this article would be worth highlighting as it addresses one of the newest and most exciting areas of cancer therapeutics.”

Cancers MDPI

Breast Cancer Brittney Shulman Zimmerman cancer Cancer research Cancers MDPI Francisco J. Esteva OncoDaily Oncology

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Blog

Nov 13, 2024, 09:39

AI tools to improve diagnosis and therapy in neuro-oncology

Insight

Nov 13, 2024, 09:27

Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening

Blog

Nov 13, 2024, 09:14

Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas

Blog

Nov 13, 2024, 09:11

Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy

Blog

Nov 13, 2024, 09:09

Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager

Blog

Nov 13, 2024, 09:01

Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer

Blog

Nov 13, 2024, 08:59

Miriam Mutebi: What To Expect During A Mammogram

Insight

Nov 13, 2024, 08:56

Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors

Insight

Nov 13, 2024, 08:51

Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing

Blog

Nov 13, 2024, 08:49

Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus

Blog

Nov 13, 2024, 08:46

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Blog

Nov 13, 2024, 08:39

Eva Blondeaux on safety of pregnancy in BRCA carriers